{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Biofilm", "Lysostaphin", "PLGA", "Staphylococcus aureus", "Vancomycin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37723466", "DateCompleted": {"Year": "2023", "Month": "09", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "18"}], "Language": ["eng"], "ELocationID": ["39", "10.1186/s12896-023-00811-8"], "Journal": {"ISSN": "1472-6750", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Sep", "Day": "18"}}, "Title": "BMC biotechnology", "ISOAbbreviation": "BMC Biotechnol"}, "ArticleTitle": "Effect of poly (lactic-co-glycolic acid) polymer nanoparticles loaded with vancomycin against Staphylococcus aureus biofilm.", "Pagination": {"StartPage": "39", "MedlinePgn": "39"}, "Abstract": {"AbstractText": ["Staphylococcus aureus is a unique challenge for the healthcare system because it can form biofilms, is resistant to the host's immune system, and is resistant to numerous antimicrobial therapies. The aim of this study was to investigate the effect of poly (lactic-co-glycolic acid) (PLGA) polymer nanoparticles loaded with vancomycin and conjugated with lysostaphin (PLGA-VAN-LYS) on inhibiting S. aureus biofilm formation. Nano drug carriers were produced using the double emulsion evaporation process. we examined the physicochemical characteristics of the nanoparticles, including particle size, polydispersity index (PDI), zeta potential, drug loading (DL), entrapment efficiency (EE), Lysostaphin conjugation efficiency (LCE), and shape. The effect of the nano drug carriers on S. aureus strains was evaluated by determining the minimum inhibitory concentration (MIC), conducting biofilm formation inhibition studies, and performing agar well diffusion tests. The average size, PDI, zeta potential, DL, EE, and LCE of PLGA-VAN-LYS were 320.5\u2009\u00b1\u200935 nm, 0.270\u2009\u00b1\u20090.012, -19.5\u2009\u00b1\u20091.3 mV, 16.75\u2009\u00b1\u20092.5%, 94.62\u2009\u00b1\u20092.6%, and 37% respectively. Both the agar well diffusion and MIC tests did not show a distinction between vancomycin and the nano drug carriers after 72 h. However, the results of the biofilm analysis demonstrated that the nano drug carrier had a stronger inhibitory effect on biofilm formation compared to the free drug. The use of this technology for treating hospital infections caused by the Staphylococcus bacteria may have favorable effects on staphylococcal infections, considering the efficacy of the nano medicine carrier developed in this study."], "CopyrightInformation": "\u00a9 2023. BioMed Central Ltd., part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR, Iran."}], "LastName": "Nouruzi", "ForeName": "Ellahe", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR, Iran. smhoseiny88@yahoo.com."}, {"Identifier": [], "Affiliation": "Infectious Disease Research Center, Hamadan University of Medical Sciences, Hamadan, IR, Iran. smhoseiny88@yahoo.com."}], "LastName": "Hosseini", "ForeName": "Seyed Mostafa", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR, Iran."}], "LastName": "Asghari", "ForeName": "Babak", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Mahjoub", "ForeName": "Reza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry, Damghan University, Damghan, IR, Iran."}], "LastName": "Zare", "ForeName": "Ehsan Nazarzadeh", "Initials": "EN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands."}], "LastName": "Shahbazi", "ForeName": "Mohammad-Ali", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology department, Hamadan University of Medical Sciences, Hamadan, IR, Iran."}], "LastName": "Kalhori", "ForeName": "Fereshte", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR, Iran. mohammad.arabestani@gmail.com."}, {"Identifier": [], "Affiliation": "Infectious Disease Research Center, Hamadan University of Medical Sciences, Hamadan, IR, Iran. mohammad.arabestani@gmail.com."}], "LastName": "Arabestani", "ForeName": "Mohammad Reza", "Initials": "MR"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Biotechnol", "NlmUniqueID": "101088663", "ISSNLinking": "1472-6750"}, "ChemicalList": [{"RegistryNumber": "6Q205EH1VU", "NameOfSubstance": "Vancomycin"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycols"}, {"RegistryNumber": "0WT12SX38S", "NameOfSubstance": "glycolic acid"}, {"RegistryNumber": "9002-18-0", "NameOfSubstance": "Agar"}, {"RegistryNumber": "EC 3.4.24.75", "NameOfSubstance": "Lysostaphin"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymers"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vancomycin"}, {"QualifierName": [], "DescriptorName": "Glycols"}, {"QualifierName": [], "DescriptorName": "Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Agar"}, {"QualifierName": [], "DescriptorName": "Lysostaphin"}, {"QualifierName": [], "DescriptorName": "Staphylococcal Infections"}, {"QualifierName": [], "DescriptorName": "Polymers"}, {"QualifierName": [], "DescriptorName": "Biofilms"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4:178.", "ArticleIdList": ["PMC4275032", "25566513"]}, {"Citation": "Neopane P, Nepal HP, Shrestha R, Uehara O, Abiko Y. In vitro biofilm formation by Staphylococcus aureus isolated from wounds of hospital-admitted patients and their association with antimicrobial resistance. Int J Gen Med. 2018;11:25\u201332.", "ArticleIdList": ["PMC5779313", "29403304"]}, {"Citation": "Parastan R, Kargar M, Solhjoo K, Kafilzadeh F. Staphylococcus aureus biofilms: structures, antibiotic resistance, inhibition, and vaccines. Gene Rep. 2020;20:100739."}, {"Citation": "Cheung GY, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547\u2013569.", "ArticleIdList": ["PMC7872022", "33522395"]}, {"Citation": "Saber T, Samir M, El-Mekkawy RM, Ariny E, El-Sayed SR, Enan G, et al. Methicillin-and vancomycin-resistant staphylococcus aureus from humans and ready-to-eat meat: characterization of antimicrobial resistance and biofilm formation ability. Front Microbiol. 2022;12:735494.", "ArticleIdList": ["PMC8861318", "35211098"]}, {"Citation": "Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Investig. 2014;124(7):2836\u20132840.", "ArticleIdList": ["PMC4071404", "24983424"]}, {"Citation": "Bruniera F, Ferreira F, Saviolli L, Bacci M, Feder D, Pedreira M, et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19(4):694.", "ArticleIdList": ["25753888"]}, {"Citation": "Otto M. Staphylococcal biofilms. Microbiol Spectr. 2018;6(4):6.4.27.", "ArticleIdList": ["PMC6282163", "30117414"]}, {"Citation": "Liu J, Madec J-Y, Bousquet-M\u00e9lou A, Haenni M, Ferran AA. Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate. Sci Rep. 2021;11(1):1\u201312.", "ArticleIdList": ["PMC7973569", "33737602"]}, {"Citation": "Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 2019;5(8):e02192.", "ArticleIdList": ["PMC6709409", "31463386"]}, {"Citation": "Fulaz S, Devlin H, Vitale S, Quinn L, O\u2019Gara JP, Casey E. Tailoring nanoparticle-biofilm interactions to increase the efficacy of antimicrobial agents against Staphylococcus aureus. Int J Nanomedicine. 2020;15:4779\u201391.", "ArticleIdList": ["PMC7354952", "32753866"]}, {"Citation": "Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother. 2003;47(11):3407\u20133414.", "ArticleIdList": ["PMC253758", "14576095"]}, {"Citation": "Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine. 2005;1(1):22\u201330.", "ArticleIdList": ["17292054"]}, {"Citation": "Iannitelli A, Grande R, Di Stefano A, Di Giulio M, Sozio P, Bessa LJ, et al. Potential antibacterial activity of carvacrol-loaded poly (DL-lactide-co-glycolide)(PLGA) nanoparticles against microbial biofilm. Int J Mol Sci. 2011;12(8):5039\u20135051.", "ArticleIdList": ["PMC3179150", "21954343"]}, {"Citation": "Devlin H, Fulaz S, Hiebner DW, O\u2019Gara JP, Casey E. Enzyme-functionalized mesoporous silica nanoparticles to target Staphylococcus aureus and disperse biofilms. Int J Nanomed. 2021;16:1929.", "ArticleIdList": ["PMC7954034", "33727807"]}, {"Citation": "G\u00f3mez-Sequeda N, Ruiz J, Ortiz C, Urquiza M, Torres R. Potent and specific antibacterial activity against Escherichia coli O157: H7 and methicillin resistant Staphylococcus aureus (MRSA) of G17 and G19 peptides encapsulated into Poly-Lactic-Co-Glycolic Acid (PLGA) nanoparticles. Antibiotics. 2020;9(7):384.", "ArticleIdList": ["PMC7400247", "32645834"]}, {"Citation": "Shariati A, Chegini Z, Ghaznavi-Rad E, Zare EN, Hosseini SM. PLGA-based nanoplatforms in drug delivery for inhibition and destruction of microbial biofilm. Front Cell Infect Microbiol. 21;12:926363. 10.3389/fcimb.2022.926363.", "ArticleIdList": ["PMC9253276", "35800390"]}, {"Citation": "Scriboni AB, Couto VM, Ribeiro LNdM, Freires IA, Groppo FC, De Paula E, et al. Fusogenic liposomes increase the antimicrobial activity of vancomycin against Staphylococcus aureus biofilm. Front Pharmacol. 2019;10:1401.", "ArticleIdList": ["PMC6895244", "31849660"]}, {"Citation": "Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607\u2013623.", "ArticleIdList": ["24794896"]}, {"Citation": "Huang Z, Zhou T, Yuan Y, K\u0142odzi\u0144ska SN, Zheng T, Sternberg C, et al. Synthesis of carbon quantum dot-poly lactic-co-glycolic acid hybrid nanoparticles for chemo-photothermal therapy against bacterial biofilms. J Colloid Interface Sci. 2020;577:66\u201374.", "ArticleIdList": ["32473477"]}, {"Citation": "Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377\u20131397.", "ArticleIdList": ["PMC3347861", "22577513"]}, {"Citation": "Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u2013522.", "ArticleIdList": ["22353619"]}, {"Citation": "Choi J-S, Seo K, Yoo J-W. Recent advances in PLGA particulate systems for drug delivery. J Pharm Investig. 2012;42:155\u2013163."}, {"Citation": "Anjum A, Chung P-Y, Ng S-F. PLGA/xylitol nanoparticles enhance antibiofilm activity via penetration into biofilm extracellular polymeric substances. RSC Adv. 2019;9(25):14198\u201314208.", "ArticleIdList": ["PMC9064039", "35519311"]}, {"Citation": "Ceotto-Vigoder H, Marques S, Santos I, Alves M, Barrias E, Potter A, et al. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis. J Appl Microbiol. 2016;121(1):101\u2013114.", "ArticleIdList": ["26999597"]}, {"Citation": "Hajiahmadi F, Alikhani MY, Shariatifar H, Arabestani MR, Ahmadvand D. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice. Int J Nanomedicine. 2019;14:5943\u201355.", "ArticleIdList": ["PMC6683660", "31447553"]}, {"Citation": "Kumar JK. Lysostaphin: an antistaphylococcal agent. Appl Microbiol Biotechnol. 2008;80:555\u2013561.", "ArticleIdList": ["18607587"]}, {"Citation": "Bastos MdCdF, Coutinho BG, Coelho MLV. Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals. 2010;3(4):1139\u201361.", "ArticleIdList": ["PMC4034026", "27713293"]}, {"Citation": "Topal GR, Kiymaci ME, \u00d6zkan Y. Preparation and in vitro characterization of vancomycin loaded PLGA nanoparticles for the treatment of Enterococcus faecalis infections. J Fac Pharm Ankara Univ. 2022;46(2):350\u201363."}, {"Citation": "He R, Zhang G, Yang J, Bai Z, Han K, Zhang H. Investigating dual drug loaded PLGA nanocarriers for improved efficacy in endometritis therapeutics. J Exp Nanosci. 2021;16(1):116\u2013131."}, {"Citation": "Moura CC, Segundo MA, Neves Jd, Reis S, Sarmento B. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application. Int J Nanomedicine. 2014;9:4911\u201322.", "ArticleIdList": ["PMC4211909", "25364249"]}, {"Citation": "Kumar DV, Aqeel S, Srinivas B, Jesudasan RE, Nayak S, Panda OP, et al. Development of PLGA based anticancer drug loaded nanoparticles for treating colorectal cancer: Cytotoxicity and Pharmacokinetic Studies. Eur Chem Bull. 2023;12(Special Issue 4):14657\u201379."}, {"Citation": "Nandagiri VK, Gentile P, Chiono V, Tonda-Turo C, Matsiko A, Ramtoola Z, et al. Incorporation of PLGA nanoparticles into porous chitosan\u2013gelatin scaffolds: Influence on the physical properties and cell behavior. J Mech Behav Biomed Mater. 2011;4(7):1318\u20131327.", "ArticleIdList": ["21783141"]}, {"Citation": "\u00dcst\u00fcn A, \u00d6rt\u00fcc\u00fc S. Evaluation of Nisin-Loaded PLGA Nanoparticles Prepared with Rhamnolipid Cosurfactant against S. aureus Biofilms. Pharmaceutics. 2022;14(12):2756.", "ArticleIdList": ["PMC9783353", "36559250"]}, {"Citation": "Baipaywad P, Mektrirat R, Manaspon C. Preparation and characterization of gallic acid-loaded PLGA hydrogel as teat sealant for preventing mastitis in dry cows. J Appl Pharm Sci. 2022;12(11):030\u201337."}, {"Citation": "Lacoma A, Us\u00f3n L, Mendoza G, Sebasti\u00e1n V, Garcia-Garcia E, Muriel-Moreno B, et al. Novel intracellular antibiotic delivery system against Staphylococcus aureus: cloxacillin-loaded poly (d, l-lactide-co-glycolide) acid nanoparticles. Nanomedicine. 2020;15(12):1189\u20131203.", "ArticleIdList": ["32370602"]}, {"Citation": "Sabee M, Awang M, Bustami Y, Hamid Z. Gentamicin loaded PLA microspheres susceptibility against Staphylococcus aureus and Escherichia coli by Kirby-Bauer and micro-dilution methods. AIP Conf Proc. 2020;2267:020032. 10.1063/5.0017438."}, {"Citation": "Lee J-H, Kim Y-G, Lee J. Inhibition of Staphylococcus aureus biofilm formation and virulence factor production by petroselinic acid and other unsaturated C18 fatty acids. Microbiol Spectr. 2022;10(3):e01330\u2013e1422.", "ArticleIdList": ["PMC9241682", "35647620"]}, {"Citation": "Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, et al. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Life Sci. 2020;256:117943.", "ArticleIdList": ["32531377"]}, {"Citation": "Posadowska U, Brzychczy-W\u0142och M, Pamu\u0142a E. Gentamicin loaded PLGA nanoparticles as local drug delivery system for the osteomyelitis treatment. Acta Bioeng Biomech. 2015;17(3):41.", "ArticleIdList": ["26687562"]}, {"Citation": "Ruiz E, Orozco VH, Hoyos LM, Giraldo LF. Study of sonication parameters on PLA nanoparticles preparation by simple emulsion-evaporation solvent technique. Eur Polymer J. 2022;173:111307."}, {"Citation": "Zakeri-Milani P, Loveymi BD, Jelvehgari M, Valizadeh H. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf, B. 2013;103:174\u2013181.", "ArticleIdList": ["23201735"]}, {"Citation": "Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105\u2013114.", "ArticleIdList": ["12106981"]}, {"Citation": "Snejdrova E, Loskot J, Martiska J, Soukup T, Prokes L, Frolov V, et al. Rifampicin-loaded PLGA nanoparticles for local treatment of musculoskeletal infections: formulation and characterization. J Drug Deliv Sci Tech. 2022;73:103435."}, {"Citation": "Ito F, Fujimori H, Makino K. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres. Colloids Surf, B. 2008;61(1):25\u201329.", "ArticleIdList": ["17719753"]}, {"Citation": "Hosseini SM, Abbasalipourkabir R, Jalilian FA, Asl SS, Farmany A, Roshanaei G, et al. Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella melitensis enclosed in macrophage: a pharmacodynamics study on J774A 1 cell line. Antimicrob Resist Infect Control. 2019;8(1):1\u201312.", "ArticleIdList": ["PMC6448226", "30988946"]}, {"Citation": "Le H, D\u00e9 E, Le Cerf D, Karakasyan C. Using Targeted Nano-Antibiotics to Improve Antibiotic Efficacy against Staphylococcus aureus Infections. Antibiotics. 2023;12(6):1066.", "ArticleIdList": ["PMC10295755", "37370385"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "18"}, {"Year": "2023", "Month": "9", "Day": "7"}, {"Year": "2023", "Month": "9", "Day": "20", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "19", "Hour": "0", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "18", "Hour": "23", "Minute": "44"}, {"Year": "2023", "Month": "9", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37723466", "PMC10506343", "10.1186/s12896-023-00811-8", "10.1186/s12896-023-00811-8"]}}], "PubmedBookArticle": []}